youtube_live
Q2 2027 earnings • released • EPS miss -3.32% • Revenue beat +1.51%
See resultschevron_right
ALKEM:NSE
Alkem Laboratories Ltd
₹5,114.00
arrow_downward
-3.55%(-188.00) 1D
Nov 13, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALKEM...
Open
₹5,300.00
High
₹5,300.50
Low
₹5,103.50
Mkt. cap
610.98B
Avg. vol.
157.66K
Volume
407.16K
Dividend
1.04%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
28.34
52-wk high
₹5,933.50
52-wk low
₹4,811.00
EPS
₹180.45
Shares outstanding
119.55M
No. of employees
19K
Open
₹5,300.00
High
₹5,300.50
Low
₹5,103.50
Mkt. cap
610.98B
Avg. vol.
157.66K
Volume
407.16K
Dividend
1.04%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
28.34
52-wk high
₹5,933.50
52-wk low
₹4,811.00
EPS
₹180.45
Shares outstanding
119.55M
No. of employees
19K
News stories
From web sources and news partners
Business Standard
·
2 days ago
Alkem shares fall 3% after Q2 results; MOFSL retains Neutral rating
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19.3K
Founded1973
HeadquartersMumbai, Maharashtra, India
SectorHealth Care
IndustryPharmaceutical industry
Websitealkemlabs.com